CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Pfizer (PFE) Starts EMA Review For Its Lyme Disease Vaccine

RegulatoryPositive
AI Analysis

Summary

Pfizer has initiated European Medicines Agency (EMA) review for its Lyme disease vaccine candidate. The regulatory submission represents a milestone in the vaccine's development path in Europe.

Importance:6/10
Sentiment:
0.30
EMAregulatoryvaccineLyme disease
Related Companies

Read the original article

Published by yahoo_finance on August 26, 2026 12:21 AM

Read Original